Conavi Medical Provides Shareholder Update and 2025 Outlook
GlobeNewswire·2025-01-23 12:00
- U.S. FDA 510(k) filing of next-generation Novasight system targeted for H2 2025 with U.S. commercial launch planned for early 2026- Evolving medical guidelines position next-generation Novasight system as new imaging standard in interventional cardiology- Multiple non-dilutive opportunities being pursued to fund growth TORONTO, Jan. 23, 2025 (GLOBE NEWSWIRE) -- To our Shareholders, As we enter 2025, I’m encouraged by our recent progress and the favorable strategic landscape. Having completed our go-publi ...